PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-2.84%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
-8.84%
Cost reduction while VET shows 1.55% growth. Joel Greenblatt would examine competitive advantage.
2.67%
Positive growth while VET shows decline. John Neff would investigate competitive advantages.
5.68%
Margin expansion while VET shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.76%
Other expenses change of 2.76% while VET maintains costs. Bruce Berkowitz would investigate efficiency.
1.42%
Operating expenses growth above 1.5x VET's 0.59%. Michael Burry would check for inefficiency.
-4.88%
Total costs reduction while VET shows 0.91% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-5.11%
D&A reduction while VET shows 3.51% growth. Joel Greenblatt would examine efficiency.
-3.21%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
20.46%
EBITDA margin growth while VET declines. John Neff would investigate advantages.
4.38%
Operating income growth while VET declines. John Neff would investigate advantages.
7.43%
Operating margin growth while VET declines. John Neff would investigate advantages.
-143.79%
Other expenses reduction while VET shows 16.40% growth. Joel Greenblatt would examine advantage.
-21.66%
Both companies show declining income. Martin Whitman would check industry conditions.
-19.37%
Both companies show margin pressure. Martin Whitman would check industry conditions.
236.79%
Tax expense growth above 1.5x VET's 97.52%. Michael Burry would check for concerning trends.
-63.06%
Both companies show declining income. Martin Whitman would check industry conditions.
-61.98%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-63.64%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-63.20%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
-2.03%
Share count reduction while VET shows 0.89% change. Joel Greenblatt would examine strategy.
-0.56%
Diluted share reduction while VET shows 2.47% change. Joel Greenblatt would examine strategy.